Surya Pharmaceutical

Experts feel the corporate governance in PSU banks is not as strong as private banks and there is lot of involvement and interfering by government officials.

Surya Pharma standalone Dec '13 sales at Rs 0.57 crore

Surya Pharmaceutical has reported a standalone sales turnover of Rs 0.57 crore and a net loss of Rs 867.83 crore for the quarter ended Dec '13

Surya Pharma standalone Sep '13 sales at Rs 4.58 crore

Surya Pharmaceutical has reported a standalone sales turnover of Rs 4.58 crore and a net loss of Rs 88.11 crore for the quarter ended Sep '13

Surya Pharma standalone Dec '12 sales at Rs 10.02 crore

Surya Pharmaceutical has reported a standalone sales turnover of Rs 10.02 crore and a net loss of Rs 77.94 crore for the quarter ended Dec '12

Surya Pharma quotes ex-dividend; stock up

Surya Pharmaceutical touched an intraday high of Rs 16.15 and an intraday low of Rs 16. At 10:21 hrs the share was quoting at Rs 16, up Rs 0.10, or 0.63%.

Surya Pharma Mar '11 sales at Rs 450.26 crore

Surya Pharmaceutical has reported a sales turnover of Rs 450.26 crore and a net profit of Rs 27.79 crore for the quarter ended Mar '11

Looking at inorganic growth opportunities: Surya Pharma

In an interview with CNBC-TV18, Hari Om Bhatia, president finance, Surya Pharmaceutical, spoke about the latest happenings in his company and sector.

Find out: SP Tulsian's top multibagger stock picks

SP Tulsian, sptulsian.com, told CNBC-TV18, how best one could play the stock market with his select multibagger stock ideas. In the short-term he is bullish on Siyaram Silk, Prakash Industries and IVRCL.

See 50% upside in Surya Pharma: Tulsian

See 50% upside in Surya Pharmaceutical in a year’s time, says SP Tulsian, sptulsian.com.

Surya Pharma Dec '10 sales at Rs 398.09 crore

Surya Pharmaceutical has reported a sales turnover of Rs 398.09 crore and a net profit of Rs 28.02 crore for the quarter ended Dec '10